95 related articles for article (PubMed ID: 19737607)
1. Gonadotropin stimulation as a challenge to calibrate cisplatin induced ovarian damage in the female rat.
Yeh J; Kim BS; Liang YJ; Peresie J
Reprod Toxicol; 2009 Dec; 28(4):556-62. PubMed ID: 19737607
[TBL] [Abstract][Full Text] [Related]
2. Baseline and stimulated serum inhibin levels as biomarkers of cisplatin-induced ovarian damage in female rats.
Yeh J; Kim BS; Liang YJ; Peresie J
Am J Obstet Gynecol; 2008 Jan; 198(1):82.e1-6. PubMed ID: 18166315
[TBL] [Abstract][Full Text] [Related]
3. Early postnatal methoxychlor exposure inhibits folliculogenesis and stimulates anti-Mullerian hormone production in the rat ovary.
Uzumcu M; Kuhn PE; Marano JE; Armenti AE; Passantino L
J Endocrinol; 2006 Dec; 191(3):549-58. PubMed ID: 17170213
[TBL] [Abstract][Full Text] [Related]
4. Protection against cisplatin-induced ovarian damage by the antioxidant sodium 2-mercaptoethanesulfonate (mesna) in female rats.
Yeh J; Kim BS; Peresie J
Am J Obstet Gynecol; 2008 Apr; 198(4):463.e1-6; discussion 463.e6-7. PubMed ID: 18395042
[TBL] [Abstract][Full Text] [Related]
5. Müllerian inhibiting substance as a novel biomarker of cisplatin-induced ovarian damage.
Yeh J; Kim B; Liang YJ; Peresie J
Biochem Biophys Res Commun; 2006 Sep; 348(2):337-44. PubMed ID: 16875679
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of different markers of the ovarian reserve in patients presenting with premature ovarian failure.
Massin N; Méduri G; Bachelot A; Misrahi M; Kuttenn F; Touraine P
Mol Cell Endocrinol; 2008 Jan; 282(1-2):95-100. PubMed ID: 18191888
[TBL] [Abstract][Full Text] [Related]
7. Anti-Müllerian hormone: correlation of early follicular, ovulatory and midluteal levels with ovarian response and cycle outcome in intracytoplasmic sperm injection patients.
Elgindy EA; El-Haieg DO; El-Sebaey A
Fertil Steril; 2008 Jun; 89(6):1670-6. PubMed ID: 17658520
[TBL] [Abstract][Full Text] [Related]
8. [Effects of gonadotropin releasing hormone analogues on chemotherapy-induced ovarian function damage in rats].
Peng P; Yang DZ; Zheng CY; Mo YQ; He YM; Zhang QX
Zhonghua Fu Chan Ke Za Zhi; 2007 Aug; 42(8):546-50. PubMed ID: 17983495
[TBL] [Abstract][Full Text] [Related]
9. Expression of anti-Müllerian hormone (AMH) in equine granulosa-cell tumors and in normal equine ovaries.
Ball BA; Conley AJ; MacLaughlin DT; Grundy SA; Sabeur K; Liu IK
Theriogenology; 2008 Oct; 70(6):968-77. PubMed ID: 18599114
[TBL] [Abstract][Full Text] [Related]
10. Basal and stimulation day 5 anti-Mullerian hormone serum concentrations as predictors of ovarian response and pregnancy in assisted reproductive technology cycles stimulated with gonadotropin-releasing hormone agonist--gonadotropin treatment.
Peñarrubia J; Fábregues F; Manau D; Creus M; Casals G; Casamitjana R; Carmona F; Vanrell JA; Balasch J
Hum Reprod; 2005 Apr; 20(4):915-22. PubMed ID: 15665015
[TBL] [Abstract][Full Text] [Related]
11. Anti-Mullerian hormone (AMH): what do we still need to know?
La Marca A; Broekmans FJ; Volpe A; Fauser BC; Macklon NS;
Hum Reprod; 2009 Sep; 24(9):2264-75. PubMed ID: 19520713
[TBL] [Abstract][Full Text] [Related]
12. Circulating basal anti-Müllerian hormone levels as predictor of ovarian response in women undergoing ovarian stimulation for in vitro fertilization.
Nardo LG; Gelbaya TA; Wilkinson H; Roberts SA; Yates A; Pemberton P; Laing I
Fertil Steril; 2009 Nov; 92(5):1586-93. PubMed ID: 18930213
[TBL] [Abstract][Full Text] [Related]
13. Development of a sensitive enzyme immunoassay for anti-Müllerian hormone and the evaluation of potential clinical applications in males and females.
Al-Qahtani A; Muttukrishna S; Appasamy M; Johns J; Cranfield M; Visser JA; Themmen AP; Groome NP
Clin Endocrinol (Oxf); 2005 Sep; 63(3):267-73. PubMed ID: 16117813
[TBL] [Abstract][Full Text] [Related]
14. Correlation of serum anti-Müllerian hormone with accelerated follicle loss following 4-vinylcyclohexene diepoxide-induced follicle loss in mice.
Sahambi SK; Visser JA; Themmen AP; Mayer LP; Devine PJ
Reprod Toxicol; 2008 Oct; 26(2):116-22. PubMed ID: 18706995
[TBL] [Abstract][Full Text] [Related]
15. Serum anti-Müllerian hormone levels remain high until late reproductive age and decrease during metformin therapy in women with polycystic ovary syndrome.
Piltonen T; Morin-Papunen L; Koivunen R; Perheentupa A; Ruokonen A; Tapanainen JS
Hum Reprod; 2005 Jul; 20(7):1820-6. PubMed ID: 15802325
[TBL] [Abstract][Full Text] [Related]
16. Decreased ovarian reserve in female Sprague-Dawley rats induced by isotretinoin (retinoic acid) exposure.
Abali R; Yuksel MA; Aktas C; Celik C; Guzel S; Erfan G; Sahin O
Reprod Biomed Online; 2013 Aug; 27(2):184-91. PubMed ID: 23768617
[TBL] [Abstract][Full Text] [Related]
17. Hormonal induction of ovulation stimulates atresia of antral follicles in a vespertilionid bat, Scotophilus heathi.
Chanda D; Abhilasha ; Krishna A
Zoology (Jena); 2006; 109(3):208-16. PubMed ID: 16814533
[TBL] [Abstract][Full Text] [Related]
18. Follicular atresia as an apoptotic process: atresia-associated increase in the ovarian expression of the putative apoptotic marker sulfated glycoprotein-2.
Hurwitz A; Ruutiainen-Altman K; Marzella L; Botero L; Dushnik M; Adashi EY
J Soc Gynecol Investig; 1996; 3(4):199-208. PubMed ID: 8796831
[TBL] [Abstract][Full Text] [Related]
19. Gonadotropin regulation of glutamate cysteine ligase catalytic and modifier subunit expression in rat ovary is subunit and follicle stage specific.
Tsai-Turton M; Luderer U
Am J Physiol Endocrinol Metab; 2005 Sep; 289(3):E391-402. PubMed ID: 15811874
[TBL] [Abstract][Full Text] [Related]
20. Steroidogenic acute regulatory protein in ovarian follicles of gonadotropin-stimulated rats is regulated by a gonadotropin-releasing hormone agonist.
Irusta G; Parborell F; Peluffo M; Manna PR; Gonzalez-Calvar SI; Calandra R; Stocco DM; Tesone M
Biol Reprod; 2003 May; 68(5):1577-83. PubMed ID: 12606484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
